| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/02/2009 | WO2009041633A1 Method of labeling membrane protein with the use of coiled coil |
| 04/02/2009 | WO2009041501A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | WO2009041415A1 Novel glucose dehydrogenase |
| 04/02/2009 | WO2009041409A1 Modified creatinine amidohydrolase |
| 04/02/2009 | WO2009040557A2 Polynucleotide primers for detecting pik3ca mutations |
| 04/02/2009 | WO2009040508A2 Methods of detection and enrichment of prpsc by immunoprecipitation and elisa |
| 04/02/2009 | WO2009040460A1 Compound of silica-vinylsulphone, synthesis and uses of the same |
| 04/02/2009 | WO2009040444A1 Rna isolation method |
| 04/02/2009 | WO2009040438A2 Markers for the prognosis of lung function and colonization with an infectious agent |
| 04/02/2009 | WO2009040220A1 Single-readout multiplexing of metagenes |
| 04/02/2009 | WO2009040002A1 Use of clec1b for the determination of cardiovascular and thrombotic risk |
| 04/02/2009 | WO2009039640A1 A system, apparatus and method for applying mechanical force to a material |
| 04/02/2009 | WO2009039639A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
| 04/02/2009 | WO2009039601A1 3.4 kb mitochondrial dna deletion for use in the detection of cancer |
| 04/02/2009 | WO2009039589A1 Cell detection, monitoring and isolation method |
| 04/02/2009 | WO2009039584A1 Diagnosis and treatment of diseased and damaged tissue |
| 04/02/2009 | WO2009039549A2 Method for determining microorganisms |
| 04/02/2009 | WO2009039542A2 Methods of screening for compounds having anti- inflammatory activity and/or prevent / treat vascular leak |
| 04/02/2009 | WO2009023725A3 Early detection of cancer by methylated dna in blood |
| 04/02/2009 | WO2009021908A3 Disposable enzymatic sensor for liquid samples |
| 04/02/2009 | WO2009021031A3 Proximity ligation assay |
| 04/02/2009 | WO2009020905A3 Ultraconserved regions encoding ncrnas |
| 04/02/2009 | WO2009019455A3 Analysis of nucleic acids of varying lengths by digital pcr |
| 04/02/2009 | WO2009012467A3 Increasing grain yield through targeted reduction in ethylene signaling |
| 04/02/2009 | WO2009012220A3 Analyte detection assays |
| 04/02/2009 | WO2009009431A3 Mipol1-etv1 gene rearrangements |
| 04/02/2009 | WO2009005753A3 System and method for adaptive reagent control in nucleic acid sequencing |
| 04/02/2009 | WO2009002947A3 Compounds and peptides that bind the trail receptor |
| 04/02/2009 | WO2009002918A9 Hepatitis c dsrna effector molecules, expression constructs, compositions, and methods of use |
| 04/02/2009 | WO2008157696A3 High throughput nucleic acid sequencing by expansion |
| 04/02/2009 | WO2008142567A3 Microrna molecules associated with inflammatory skin disorders |
| 04/02/2009 | WO2008140793A3 Polynucleotides associated with age-related macular degeneration and methods for evaluating patient risk |
| 04/02/2009 | WO2008137383A9 Markers and methods for assessing and treating ulcerative colitis and related disorders using a 19 gene panel |
| 04/02/2009 | WO2008132464A3 Mek5 and related proteins as biomarkers of neurodegenerative diseases |
| 04/02/2009 | WO2008122794A3 Breast cancer methods, medicaments and agents |
| 04/02/2009 | WO2008101701A3 Organism-specific hybridizable nucleic acid molecule |
| 04/02/2009 | WO2008091708A3 Gene expression profiling for identification, monitoring, and treatment of lupus erythematosus |
| 04/02/2009 | WO2008070663A3 Companion diagnostic assays for cancer therapy |
| 04/02/2009 | WO2008070144A3 Imprinted genes and disease |
| 04/02/2009 | WO2008051285A3 Methods and compositions for detecting fungi and mycotoxins |
| 04/02/2009 | WO2008028086A9 Methods and substances for isolation and detection of small polynucleotides |
| 04/02/2009 | WO2008021183A3 For the identification, assessment, and treatment of patients with cancer therapy |
| 04/02/2009 | WO2008011180A3 Methods and compositions for amplification and capture of nucleic acid sequences |
| 04/02/2009 | WO2008002911A3 Urate metabolites as diagnostic markers for cardiovascular and renal disease |
| 04/02/2009 | WO2008002483A3 Reagent preparation and valving design for liquid testing |
| 04/02/2009 | WO2007130967A3 Novel oligonucleotide primers and methods for dna replication |
| 04/02/2009 | WO2006063133A3 Biomarker for inflammatory bowel disease |
| 04/02/2009 | WO2006052852A3 Kit for in process quality control to predict and determine engraftment and multilineage reconstitution potential of hematopoietic cells and cord blood storage |
| 04/02/2009 | WO2006041524A3 Nucleic acid detection system |
| 04/02/2009 | WO2006036848A3 Multiple bead reagent system for protein based assays with optimized matrices |
| 04/02/2009 | WO2006034300A3 Great wall kinases and uses thereof |
| 04/02/2009 | WO2006031688A3 Method of separating tumor cells with and without lymphotropic metastatic potential in a human carcinoma |
| 04/02/2009 | WO2006028585A3 Optical fiber bundle for detecting binding of chemical species |
| 04/02/2009 | WO2006028492A3 hC1Q/TNF7 AND USES THEREOF |
| 04/02/2009 | WO2006024020A3 Hcv non-structural protein mutants and uses thereof |
| 04/02/2009 | WO2006023495A3 Carotenoid hydroxylase enzymes |
| 04/02/2009 | WO2005123913A3 Reversibly modified thermostable enzyme compositions and methods of making and using the same |
| 04/02/2009 | WO2005121323A3 Methods for ex vivo propagation of somatic hair follicle stem cells |
| 04/02/2009 | WO2005116259A3 Use of gene expression profiling to predict survival in cancer patient |
| 04/02/2009 | WO2005113820A3 Methods and devices related to a regulated flow electroporation chamber |
| 04/02/2009 | WO2005081716A3 DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) |
| 04/02/2009 | WO2005076984A3 Thymidylate synthase gene and metastasis |
| 04/02/2009 | WO2005059507A3 Biosensor and method of making same |
| 04/02/2009 | WO2005059094A3 Novel methods of inorganic compound discovery and synthesis |
| 04/02/2009 | WO2005054548A3 Methods, compositions, and kits for protein crystallization |
| 04/02/2009 | WO2005054433A3 A novel “cleave-n-read” system for protease activity assay and methods of use thereof |
| 04/02/2009 | WO2005047477A3 Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai |
| 04/02/2009 | WO2005044974A3 Cell death-related nucleases and their uses |
| 04/02/2009 | WO2005030930A3 Variants of cyan fluorescent protein with improved fluorescent properties |
| 04/02/2009 | WO2005023986A3 Microrna as ligands and target molecules |
| 04/02/2009 | WO2005019430A3 In vitro selection of aptamer beacons |
| 04/02/2009 | WO2005013081A3 Methods and systems for applying genetic operators to determine system conditions |
| 04/02/2009 | WO2005002416A3 Predictors of renal disease |
| 04/02/2009 | WO2004094456A3 Immuno-amplification |
| 04/02/2009 | WO2003012026A8 Apparatus and method for determining the onset and presence of sepsis conditions |
| 04/02/2009 | US20090089891 Transcription factor stress-related proteins and methods of use in plants |
| 04/02/2009 | US20090088982 Co-detection of single polypeptide and polynucleotide molecules |
| 04/02/2009 | US20090088563 Consisting of a sense and antisense region that form a duplex region; and from zero to one overhang regions; gene silencing, gene expression inhibition; gene therapy, drug discovery; cancer, Alzheimer's disease, diabetes |
| 04/02/2009 | US20090088559 Method for preparing modified polypeptides |
| 04/02/2009 | US20090088558 Tumor necrosis factor specific antibody hybrid for use in treatment and prevention of autoimmune, rheumatoid arthritic, graft rejection and graft-versus-host disorder |
| 04/02/2009 | US20090088555 44 Human Secreted Proteins |
| 04/02/2009 | US20090088473 Method for screening of prostaglandin compounds comprising an optimal formulation for the enhancement of hair growth and the stimulation of follicular anagen and formulations resulting therefrom |
| 04/02/2009 | US20090088444 Substituted phenanthrene diketo acids and uses therefor |
| 04/02/2009 | US20090088409 Serum biomarkers for early detection of acute cellular rejection |
| 04/02/2009 | US20090088400 Prostaglandin e2 modulation and uses thereof |
| 04/02/2009 | US20090088391 Strains of Lactobacillus Helveticus which do not Ferment Lactose |
| 04/02/2009 | US20090088339 Identification of activated receptors and ion channels |
| 04/02/2009 | US20090088337 RET-Based Analyte Detection |
| 04/02/2009 | US20090088335 Nucleic acid sequencing by single-base primer extension |
| 04/02/2009 | US20090088329 Multicomponent protein microarrays |
| 04/02/2009 | US20090087922 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 04/02/2009 | US20090087913 Analysis of conjugated metabolites of alcohol consumption |
| 04/02/2009 | US20090087906 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 04/02/2009 | US20090087877 Infectivity assay |
| 04/02/2009 | US20090087876 Methods and compositions useful for modulating drug-induced impairment |
| 04/02/2009 | US20090087875 Alzheimer's related proteins and methods of use |
| 04/02/2009 | US20090087874 Glucose dehydrogenase and production thereof |
| 04/02/2009 | US20090087873 Sharply resolving labeled protein molecular weight standards |
| 04/02/2009 | US20090087872 Assay for in vitro testing of enzyme catalytic activity |
| 04/02/2009 | US20090087871 Method for Identifying PDE5-Modulators |